Segall Bryant & Hamill’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,200
| Closed | -$279K | – | 760 |
|
|
2021
Q4 | $279K | Sell |
2,200
-60
| -3% | -$7.61K | ﹤0.01% | 560 |
|
|
2021
Q3 | $296K | Sell |
2,260
-35
| -2% | -$4.58K | ﹤0.01% | 698 |
|
|
2021
Q2 | $408K | Sell |
2,295
-6
| -0.3% | -$1.07K | ﹤0.01% | 648 |
|
|
2021
Q1 | $377K | Buy |
2,301
+6
| +0.3% | +$983 | ﹤0.01% | 689 |
|
|
2020
Q4 | $379K | Hold |
2,295
| – | – | ﹤0.01% | 622 |
|
|
2020
Q3 | $327K | Hold |
2,295
| – | – | ﹤0.01% | 614 |
|
|
2020
Q2 | $255K | Hold |
2,295
| – | – | ﹤0.01% | 714 |
|
|
2020
Q1 | $229K | Hold |
2,295
| – | – | ﹤0.01% | 720 |
|
|
2019
Q4 | $340K | Hold |
2,295
| – | – | 0.01% | 718 |
|
|
2019
Q3 | $293K | Hold |
2,295
| – | – | ﹤0.01% | 738 |
|
|
2019
Q2 | $327K | Sell |
2,295
-50
| -2% | -$7.12K | ﹤0.01% | 727 |
|
|
2019
Q1 | $335K | Hold |
2,345
| – | – | 0.01% | 720 |
|
|
2018
Q4 | $291K | Hold |
2,345
| – | – | 0.01% | 740 |
|
|
2018
Q3 | $394K | Hold |
2,345
| – | – | 0.01% | 723 |
|
|
2018
Q2 | $404K | Buy |
+2,345
| New | +$404K | 0.01% | 708 |
|